Published in Volume 8, Issue 4 on February 22, 2023
JCI Insight. 2023;8(4):e169516. https://doi.org/10.1172/jci.insight.169516.
© 2023 Grabauskas et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Original citation: JCI Insight. 2019;4(17):e130402. https://doi.org/10.1172/jci.insight.130402

Citation for this retraction: JCI Insight. 2023;8(4):e169516. https://doi.org/10.1172/jci.insight.169516

The University of Michigan recently notified JCI Insight of concerns regarding the identity of the antibodies used in Figure 2. JCI Insight previously issued a corrigendum to update the source of the TRESK and CCK-AR antibodies used for immunocytochemistry; however, the antibodies listed in the corrigendum were not correct (1). The institutional investigation determined that there was falsification of immunocytochemistry data by the improper description of the species of antibody used in Figure 2 and that falsified data were intentionally, knowingly, or recklessly included in the publication. Due to the intentional inclusion of falsified data and continued concerns over the identity of antibodies, JCI Insight is retracting this article.

Footnotes References